cabergoline has been researched along with thyroxine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Keogh, MA; Wittert, GA | 1 |
| Georgieva, J; Nussbaum, G; Rochlitz, H; Steinhoff, M; Zouboulis, CC | 1 |
| Assaker, R; Blond, S; Cortet-Rudelli, C; Defoort-Dhellemmes, S; Faivre-Defrance, F; Mouton, F; Soto-Ares, G; Vantyghem, MC; Wemeau, JL | 1 |
| Bolu, E; Kebapcilar, L; Kutlu, M; Sahin, M; Taslipinar, A; Uckaya, G | 1 |
| Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S | 1 |
| Beyerbach, M; Dieleman, SJ; Eschricht, FM; Günzel-Apel, AR; Hoppen, HO; Koivisto, M; Kramer, S; Mischke, R; Seefeldt, A; Urhausen, C | 1 |
| Beyerbach, M; Eschricht, F; Günzel-Apel, AR; Hoppen, HO; Koivisto, MB; Oei, CH; Urhausen, C | 1 |
| Ajitkumar, G; Ghosh, KN; Mercy, KA; Praseeda, R; Sreekumaran, T | 1 |
| Díez, JJ; Iglesias, P | 1 |
| Barbieri, F; Culler, MD; Ferone, D; Florio, T; Gatti, M; Gatto, F; Giusti, M; Hofland, LJ; Minuto, F; Ravetti, JL; Saveanu, A; Schulz, S; Wurth, R; Zona, G | 1 |
| Bakoto, N; Baleriaux, D; Boscolo, M; Corvilain, B; Devuyst, F | 1 |
| Schäfer-Somi, S; Schwendenwein, I; Sontas, BH | 1 |
| Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA | 1 |
| Chia, YY; Goh, GH; Mohan, N; Teo, K; Ting, E; Yeo, TT | 1 |
| Abe, T; Ebashi, R; Koguchi, M; Masuoka, J; Nakahara, Y; Ogata, A; Shimokawa, S | 1 |
2 review(s) available for cabergoline and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acute aseptic meningitis as the initial presentation of a macroprolactinoma.
Topics: Adult; Anti-Bacterial Agents; Blindness; Cabergoline; Combined Modality Therapy; Ergolines; Fever; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Hypopituitarism; Male; Meningitis, Aseptic; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma; Sella Turcica; Third Ventricle; Thyroxine | 2014 |
1 trial(s) available for cabergoline and thyroxine
| Article | Year |
|---|---|
Effects of short-term hyper- and hypoprolactinaemia on hormones of the pituitary, gonad and -thyroid axis and on semen quality in male Beagles.
Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Dopamine Antagonists; Ergolines; Luteinizing Hormone; Male; Metoclopramide; Pituitary Gland; Prolactin; Semen; Testis; Testosterone; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 2009 |
13 other study(ies) available for cabergoline and thyroxine
| Article | Year |
|---|---|
Effect of cabergoline on thyroid function in hyperprolactinaemia.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Thyrotropin; Thyroxine | 2002 |
Reduced growth of beard as the only diagnostic sign in a patient with macroprolactinoma.
Topics: Adenoma; Adult; Cabergoline; Dopamine Agonists; Ergolines; Face; Hair; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Testosterone; Thyroxine | 2007 |
TSH-secreting adenoma improved with cabergoline.
Topics: Adult; Antineoplastic Agents; Bone and Bones; Cabergoline; Ergolines; Humans; Male; Pituitary Neoplasms; Thyrotropin; Thyroxine; Triiodothyronine | 2008 |
Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin's lymphoma in a patient with pituitary acromegaly.
Topics: Acromegaly; Adenoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Cyclophosphamide; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Octreotide; Prednisone; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Vincristine | 2009 |
Misdiagnosis due to the hook effect in prolactin assay.
Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Female; Glucocorticoids; Humans; Hypopituitarism; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prednisolone; Prolactin; Prolactinoma; Thyroxine | 2008 |
Effects of gonadectomy on prolactin and LH secretion and the pituitary-thyroid axis in male dogs.
Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Kinetics; Luteinizing Hormone; Male; Orchiectomy; Pituitary Gland; Prolactin; Testis; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 2009 |
Comparative efficacy of bromocriptine, cabergoline and thyroxine in inducing oestrus in bitches.
Topics: Animals; Bromocriptine; Cabergoline; Dogs; Ergolines; Estrous Cycle; Female; Fertilization; Hormone Antagonists; Litter Size; Progesterone; Prolactin; Thyroxine | 2010 |
Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
Topics: Anemia; Antineoplastic Agents; Biomarkers, Tumor; Cabergoline; Chronic Disease; Dopamine Agonists; Drug Therapy, Combination; Early Detection of Cancer; Ergolines; Hematocrit; Hemoglobins; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypogonadism; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyroxine; Treatment Outcome | 2011 |
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.
Topics: Adenoma; Adult; Cabergoline; Cell Proliferation; Dopamine; Dopamine Agonists; Drug Synergism; Ergolines; Gene Expression; Humans; Immunohistochemistry; Male; Octreotide; Pituitary Neoplasms; Protein Isoforms; Receptors, Dopamine D2; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; Somatostatin; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine; Tumor Cells, Cultured | 2012 |
Primary anestrus due to dietary hyperthyroidism in a miniature pinscher bitch.
Topics: Administration, Oral; Anestrus; Animal Feed; Animals; Cabergoline; Diagnosis, Differential; Dog Diseases; Dogs; Ergolines; Female; Humans; Hyperthyroidism; Pedigree; Pregnancy; Pregnancy, Animal; Thyroxine | 2014 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders | 2015 |
Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective.
Topics: Adult; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diagnosis, Differential; Dopamine Agonists; Ergolines; Fibrosis; Humans; Hypogonadism; Hypothyroidism; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Thyroxine; Tricuspid Valve Insufficiency | 2017 |
Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
Topics: Adult; Anticonvulsants; Cabergoline; Dopamine Agonists; Fatigue; Frontal Lobe; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Status Epilepticus; Thyroxine; Treatment Outcome; Vision Disorders | 2019 |